Humanigen, Inc. Common Stock

YTD

ALL

Why Robinhood?

You can watch HGEN and buy or sell other stocks, options, and ETFs commission-free!

About HGEN

Humanigen, Inc. is a clinical-stage biopharmaceutical company. engages in the development of cell and gene therapies for the treatment of cancers through novel human granulocyte-macrophage colony-stimulating factor neutralization and gene-knockout platforms. The company was founded by Jeng-Horng Her & Robert F.

CEO

Cameron Durrant, MD, MBA

CEOCameron Durrant, MD, MBA

Employees

—

Employees—

Headquarters

Essex County, New Jersey

HeadquartersEssex County, New Jersey

Founded

2000

Founded2000

Employees

—

Employees—

HGEN Key Statistics

Market cap

11.91K

Market cap11.91K

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

33.50K

Average volume33.50K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.207

52 Week high$0.207

52 Week low

—

52 Week low—